Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Best Weight Loss Drug Stocks to Buy in 2026
11:15pm, Wednesday, 20'th May 2026
Demand for weight-loss drugs has exploded, with material differentiation among the players in the niche. There's a clear leader, but that may not be the best investment option for you in 2026.
Eli Lilly accuses church bishops, businessmen of fraud in Trulicity drug rebate scheme
10:58am, Wednesday, 20'th May 2026
Eli Lilly has disclosed in a civil lawsuit filed in federal court on Tuesday that a rebate fraud scheme cost it more than $200 million. The company alleges several bishops and a leader of the Church o
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
04:19pm, Tuesday, 19'th May 2026
The iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is the rare fund that has spent the past year being publicly threatened by the President of the United States and quietly outperforming nearly every
Silver Economy Investing: Why the Healthcare Giants Are in Focus
04:01pm, Tuesday, 19'th May 2026
Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
If You Hold This Healthcare ETF, You're Losing Big
11:12am, Tuesday, 19'th May 2026
The Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) is down about 5% year to date while the S&P 500 is up 7%.
Eli Lilly: Novo Nordisk Was Just A Warm-Up
10:00am, Tuesday, 19'th May 2026
Novo Nordisk (NOVO) is no longer viewed as a near-term threat, leaving Lilly's (LLY) Tirzepatide to dominate the injectable obesity and Type 2 Diabetes markets for ~1.5-2 years. I expect Foundayo to c
Eli Lilly Is A Buy (Technical Analysis)
01:42am, Tuesday, 19'th May 2026
Eli Lilly exhibits strong bullish technicals, with price action, momentum, and relative strength all supporting a continued uptrend. Despite an 'F' valuation grade, LLY's growth, profitability, and up
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party
08:45pm, Monday, 18'th May 2026
There is a need for more weight loss drug options, including oral pills. Viking Therapeutics is working on a promising one, though tolerability might be an issue.
Eli Lilly Stock: Next Stop $2,000?
06:30pm, Monday, 18'th May 2026
The company is riding an incredible tailwind.
Three Biotechs That Are Top Takeover Targets
01:55pm, Monday, 18'th May 2026
Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reasons are obvious: Mounjaro revenue jumped 125% to $8.66 billion last quarter, the company raised full-
Supreme Court Rejects Eli Lilly Appeal In Medicaid Fraud Case
01:42pm, Monday, 18'th May 2026
The U.S. Supreme Court declined to hear an appeal from Eli Lilly & Co. (NYSE:LLY), leaving in place a $194 million whistleblower judgment tied to allegations that the drugmaker underpaid Medicaid reba
3 Deeply Undervalued Stocks You Can Buy for Less Than $100 Right Now
12:00pm, Monday, 18'th May 2026
Shares of Pfizer, Novo Nordisk, and PDD Holdings trade at incredibly low valuations right now. These stocks are trading at significant discounts relative to their future earnings.
Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference
11:00am, Monday, 18'th May 2026
Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference PR Newswire INDIANAPOLIS, May 18,
Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference
10:00am, Monday, 18'th May 2026
INDIANAPOLIS, May 18, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 28, 2026. Daniel M. Skovronsky, M.D.
US Supreme Court turns away Eli Lilly's challenge to whistleblower law
09:43am, Monday, 18'th May 2026
The U.S. Supreme Court declined on Monday to hear a challenge by drugmaker Eli Lilly to a Civil War-era whistleblower law that has recovered billions of dollars by allowing private individuals t
